SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001829126-22-009190
Filing Date
2022-04-29
Accepted
2022-04-29 16:33:45
Documents
1
Period of Report
2022-04-14

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 27969
  Complete submission text file 0001829126-22-009190.txt   30130
Mailing Address 512 W 22ND STREET 7TH FLOOR NEW YORK NY 10111
Business Address 512 W 22ND STREET 7TH FLOOR NEW YORK NY 10111 646-597-6995
PURA VIDA INVESTMENTS, LLC (Reporting) CIK: 0001590144 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-37648 | Film No.: 22876270

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O PURA VIDA INVESTMENTS, LLC 512 W 22ND STREET, 7TH FLOOR NEW YORK NY 10011
Business Address
Kamen Efrem (Reporting) CIK: 0001789193 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37648 | Film No.: 22876269